CASP9 and type 2 diabetes mellitus: In contrast, Myr (300 mg/kg) treatment could attenuate (p < 0.01) the activation of Bad, Cyt C, caspase 9, and caspase 3 in the renal cells of T2D rats (Figure 12a,b).